Using chemotherapy against metastatic pancreatic neuroendocrine neoplasm: how aggressively do we treat it? Real world data from a Brazilian Cancer Center

Using chemotherapy against metastatic pancreatic neuroendocrine neoplasm: how aggressively do we treat it? Real world data from a Brazilian Cancer Center

Introduction: Pancreatic neuroendocrine neoplasms (pNEN) have poor prognosis. Available treatment options are limited. We aimed to evaluate the clinical characteristics and outcomes in patients with pNEN undergoing systemic chemotherapy. Methods: Retrospective s...

Full description

Bibliographic Details
Main Authors: Mauro Daniel Spina Donadio, Victor Hugo Fonseca de Jesus, Milton José Barros
Format: Article
Language:English
Published: Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2022-10-01
Series:Brazilian Journal of Oncology
Subjects:
neuroendocrine tumors
pancreatic neoplasms
drug therapy
Online Access:https://www.brazilianjournalofoncology.com.br/details/185/en-US/using-chemotherapy-against-metastatic-pancreatic-neuroendocrine-neoplasm--how-aggressively-do-we-treat-it--real-world-data-from-a-brazilian-cancer-cen

Internet

https://www.brazilianjournalofoncology.com.br/details/185/en-US/using-chemotherapy-against-metastatic-pancreatic-neuroendocrine-neoplasm--how-aggressively-do-we-treat-it--real-world-data-from-a-brazilian-cancer-cen

Similar Items